| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/14/2008 | WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF |
| 02/14/2008 | WO2008018488A1 Antibacterial agent |
| 02/14/2008 | WO2008018103A1 Product, suitable to be given to the human body for its protective effects and health benefits, based on cow buffalo's milk self-enriched with lactoferrin, or pure lactoferrin, obtained through membrane separative processes |
| 02/14/2008 | WO2008017955A1 Novel phosphopeptides and uses thereof in preventing kidney stone formation |
| 02/14/2008 | WO2008017906A1 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
| 02/14/2008 | WO2008017894A1 Peptide for treatment of asthma |
| 02/14/2008 | WO2008017863A2 Crystal structure of p53 mutants and their use |
| 02/14/2008 | WO2008017859A2 Ligand for the g6b receptor on blood platelets |
| 02/14/2008 | WO2008017831A1 Secreted vit domain containing proteins |
| 02/14/2008 | WO2008017826A2 Immunogenic proteins of burkholderia pseudomallei and uses thereof |
| 02/14/2008 | WO2008017706A1 Method of increasing resistance against soybean rust in transgenic plants |
| 02/14/2008 | WO2008017636A2 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 02/14/2008 | WO2008017603A1 G-csf site-specific mono-conjugates |
| 02/14/2008 | WO2008017598A2 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
| 02/14/2008 | WO2008017517A1 Immunogenic peptides and their use in immune disorders |
| 02/14/2008 | WO2008017483A2 Spore surface displays of bioactive molecules |
| 02/14/2008 | WO2007146171A3 Purified high molecular weight adiponectin and uses thereof |
| 02/14/2008 | WO2007108990A3 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| 02/14/2008 | WO2007084021A3 Compositions and methods for diagnosing hiv-2 infection |
| 02/14/2008 | WO2007081824A3 Fibrillation resistant proteins |
| 02/14/2008 | WO2007065098A3 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 02/14/2008 | WO2007059715A8 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 02/14/2008 | WO2007058267A8 Novel protein and gene encoding the protein |
| 02/14/2008 | WO2007052096A3 Production of bone morphogenic proteins (bmps) in transgenic mammals |
| 02/14/2008 | WO2007051201A3 Tlr3 glycosylation site muteins and methods of use |
| 02/14/2008 | WO2007039903A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 02/14/2008 | US20080040827 Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor |
| 02/14/2008 | US20080039656 Synthesis and Application of Procainamide Analogs for Use in an Immunoassay |
| 02/14/2008 | US20080039532 Compounds For Specific Viral Target |
| 02/14/2008 | US20080039486 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 02/14/2008 | US20080039413 Novel compositions and methods in cancer |
| 02/14/2008 | US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof |
| 02/14/2008 | US20080039409 Method of Suppressing Cancer |
| 02/14/2008 | US20080039402 Peptides and Peptidomimetics Binding to Cd23 |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 02/14/2008 | US20080039393 Metal-binding therapeutic peptides |
| 02/14/2008 | US20080039388 Derived from the chain of the (B)beta(15-42)-fibrin fragment substituted by genetically encoded or not genetically encoded amino acids or peptidomimetics; cysteine modified by succinimido-polyoxyethylene glycol; antiinflammatory agents; endothelium stabilizers |
| 02/14/2008 | US20080039387 Specific peptide conjugates with high modulating effect on melanocortin receptors; anorectic drug or energy expenditure regulating drug |
| 02/14/2008 | US20080039385 Neublastin Variants |
| 02/14/2008 | US20080039384 Antiangiogenic Peptides |
| 02/14/2008 | US20080039382 Compositions related to pleiotrophin methods and uses thereof |
| 02/14/2008 | US20080039373 Pegylated Factor VII Glycoforms |
| 02/14/2008 | US20080039372 Human chorionic gonadotropin antagonists and methods to prevent ovarian hyperstimulation |
| 02/14/2008 | US20080039371 Erythropoietin Liquid Formulation |
| 02/14/2008 | US20080039370 Stable Oxidation Resistant Powdered Hemoglobin, Methods of Preparing Same, and Uses Thereof |
| 02/14/2008 | US20080039341 Unstructured recombinant polymers and uses thereof |
| 02/14/2008 | US20080038824 Composition and Method for Elevating Gene Transfer Efficiency |
| 02/14/2008 | US20080038809 ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES |
| 02/14/2008 | US20080038792 Polyunsaturated fatty acids (PUFA); FabA-like beta-hydroxy acyl-ACP dehydrase activity and enoyl ACP-reductase activity; recombinant plant/microbial cells |
| 02/14/2008 | US20080038791 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038790 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038777 Synthetic dog/human chimeric C-C chemokine receptor 2B |
| 02/14/2008 | US20080038775 Method of Synthesizing and Purifying Dkk Proteins and Dkk Proteins Obtained Thereby |
| 02/14/2008 | US20080038756 Botulinum toxin substrate comprising fluorphore and clostridial toxin recognition sequence for use in detecting clostridial protease activity |
| 02/14/2008 | US20080038741 T1R taste receptors and genes encoding same |
| 02/14/2008 | US20080038735 Tus DNA binding domains |
| 02/14/2008 | US20080038723 Functional assessment of DNA mismatch repair gene variants |
| 02/14/2008 | US20080038717 Enrichment method for variant proteins with altered binding properties |
| 02/14/2008 | US20080038716 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 02/14/2008 | US20080038378 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038365 TRPC6 involved in glomerulonephritis |
| 02/14/2008 | US20080038352 Electroprocessed Collagen and Tissue Engineering |
| 02/14/2008 | US20080038319 Stimulating protective antibodies against enterotoxigenic Escherichia coli; carbonated beverages |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038248 Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof |
| 02/14/2008 | US20080038247 Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| 02/14/2008 | US20080038235 Methods for regulating T cell subsets by modulating transcription factor activity |
| 02/14/2008 | US20080038232 Production of high mannose proteins in plant culture |
| 02/14/2008 | US20080038224 Modified interferon-beta (IFN-beta) polypeptides |
| 02/14/2008 | US20080038223 WSX-1/P28 as a target for anti-inflammatory responses |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038200 Model for neurodegenerative diseases involving amyloid accumulation |
| 02/14/2008 | US20080038191 Radiolabeled Compounds And Compositions, Their Precursors And Methods For Their Production |
| 02/14/2008 | CA2695951A1 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
| 02/14/2008 | CA2695306A1 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 02/14/2008 | CA2660615A1 G-csf site-specific mono-conjugates |
| 02/14/2008 | CA2660605A1 Immunogenic peptides and their use in immune disorders |
| 02/14/2008 | CA2660438A1 Genes and polypeptides relating to breast cancers |
| 02/14/2008 | CA2660040A1 Method of increasing resistance against soybean rust in transgenic plants |
| 02/14/2008 | CA2659337A1 Combination therapy |
| 02/14/2008 | CA2642494A1 Novel phosphopeptides and uses thereof in preventing kidney stone formation |
| 02/13/2008 | EP1887081A2 DNA Sequences |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1885855A2 Cytokine receptor modulators and uses thereof |
| 02/13/2008 | EP1885815A1 Molecular glue |
| 02/13/2008 | EP1885754A2 T cell receptors which specifically bind to vygfvracl-hla-a24 |
| 02/13/2008 | EP1885753A1 Production of recombinant il-18 binding protein |
| 02/13/2008 | EP1885752A2 Modified leukocyte ig-like receptor family members (lir's) with increased affinity for class i mhc and their uses in modulating t cell activation |
| 02/13/2008 | EP1885751A1 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof |
| 02/13/2008 | EP1885750A1 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof |
| 02/13/2008 | EP1885749A1 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof |
| 02/13/2008 | EP1885748A2 Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease |
| 02/13/2008 | EP1885747A1 Erythropoietin variants |